Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia

References

• Amico, K. R., Konkle-Parker, D. J., Cornman, D. H., Barta, W. D., Ferrer, R., Norton, W. E., … Fisher, W. A. (2007). Reasons for ART non-adherence in the Deep South: Adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care, 19, 1210–1218. doi:10.1080/09540120701426516
   PubMed Web of Science ®Google Scholar
• Berg, M. B., Safren, S. A., Mimiaga, M. J., Grasso, C., Boswell, S., & Mayer, K. H. (2005). Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care, 17, 902–907. doi:10.1080/09540120500101658
   PubMed Web of Science ®Google Scholar
• Buchacz, K., Baker, R. K., Palella, F. J., Jr., Chmiel, J. S., Lichtenstein, K. A., Novak, R. M., … Brooks, J. T. (2010). AIDS-defining opportunistic illnesses in US patients, 1994–2007: A cohort study. AIDS, 24, 1549–1559. doi:10.1097/QAD.0b013e32833a3967
   PubMed Web of Science ®Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255–266. doi:10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Ghidei, L., Simone, M. J., Salow, M. J., Zimmerman, K. M., Paquin, A. M., Skarf, L. M., … Rudolph, J. L. (2013). Aging, antiretrovirals, and adherence: A meta analysis of adherence among older HIV-infected individuals. Drugs & Aging, 10, 809–819. doi:10.1007/s40266-013-0107-7
   Web of Science ®Google Scholar
• Giordano, T. P., Gifford, A. L., White, A. C., Jr., Suarez-Almazor, M. E., Rabeneck, L., Hartman, C., … Morgan, R. O. (2007). Retention in care: A challenge to survival with HIV infection. Clinical Infectious Diseases, 44, 1493–1499. doi:10.1086/516778
   PubMed Web of Science ®Google Scholar
• Hall, H. I., Frazier, E. L., Rhodes, P., Holtgrave, D. R., Furlow-Parmley, C., Tang, T., … Skarbinski, J. (2013). Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Internal Medicine, 173, 1337–1344. doi:10.1001/jamainternmed.2013.6841
   PubMed Web of Science ®Google Scholar
• Kempf, M. C., McLeod, J., Boehme, A. K., Walcott, M. W., Wright, L., Seal, P., … Moneyham, L. (2010). A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: Implications for targeted interventions. AIDS Patient Care and STDs, 24, 515–520. doi:10.1089/apc.2010.0065
   PubMed Web of Science ®Google Scholar
• Milloy, M. J., Marshall, B. D., Montaner, J., & Wood, E. (2012). Housing status and the health of people living with HIV/AIDS. Current HIV/AIDS Reports, 9, 364–374. doi:10.1007/s11904-012-0137-5
   PubMed Web of Science ®Google Scholar
• Mugavero, M. J., Lin, H. Y., Willig, J. H., Westfall, A. O., Ulett, K. B., Routman, J. S., … Allison, J. J. (2009). Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clinical Infectious Diseases, 48, 248–256. doi:10.1086/595705
   PubMed Web of Science ®Google Scholar
• Ohl, M., Tate, J., Duggal, M., Skanderson, M., Scotch, M., Kaboli, P., … Justice, A. (2010). Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection. Medical Care, 48, 1064–1070. doi:10.1097/MLR.0b013e3181ef60c2
   PubMed Web of Science ®Google Scholar
• Park, W. B., Choe, P. G., Kim, S. H., Jo, J. H., Bang, J. H., Kim, H. B., … Choe, K. W. (2007). One-year adherence to clinic visits after highly active antiretroviral therapy: A predictor of clinical progress in HIV patients. Journal of Internal Medicine, 261, 268–275. doi:10.1111/j.1365-2796.2006.01762.x
   PubMed Web of Science ®Google Scholar
• Pirrone, V., Libon, D. J., Sell, C., Lerner, C. A., Nonnemacher, M. R., & Wigdahl, B. (2013). Impact of age on markers of HIV-1 disease. Future Virology, 8(1), 81–101. doi:10.2217/fvl.12.127
   PubMed Web of Science ®Google Scholar
• Rastegar, D. A., Fingerhood, M. I., & Jasinski, D. R. (2003). Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care, 15, 231–237. doi:10.1080/0954012031000068371
   PubMed Web of Science ®Google Scholar
• Reif, S., Golin, C. E., & Smith, S. R. (2005). Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences. AIDS Care, 17, 558–565. doi:10.1080/09540120412331319750
   PubMed Web of Science ®Google Scholar
• Schneider, E., Whitmore, S., Glynn, K. M., Dominguez, K., Mitsch, A., & McKenna, M. T. (2008). Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years – United States, 2008. MMWR Recommendations and Reports, 57(RR-10), 1–12.
   PubMedGoogle Scholar
• Shacham, E., Lian, M., Onen, N. F., Donovan, M., & Overton, E. T. (2013). Are neighborhood conditions associated with HIV management? HIV Medicine, 14, 624–632. doi:10.1111/hiv.12067
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Yard, S. S., & Huh, D. (2013). Prospective prediction of viral suppression and immune response nine months after ART initiation in Seattle, WA. AIDS Care, 25, 181–185. doi:10.1080/09540121.2012.687821
   PubMed Web of Science ®Google Scholar
• Weintrob, A. C., Fieberg, A. M., Agan, B. K., Ganesan, A., Crum-Cianflone, N. F., Marconi, V. C., … Wortmann, G. W. (2008). Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART. Journal of Acquired Immune Deficiency Syndromes, 49(1), 40–47. doi:10.1097/QAI.0b013e31817bec05
   PubMed Web of Science ®Google Scholar